The dynamic interplay between a PTK (Kit) and a PTP (Shp2) in hematopoietic stem and progenitor cells.
作者信息
Zhu Helen He, Feng Gen-Sheng
出版信息
Cell Cycle. 2011 Jul 15;10(14):2241-2. doi: 10.4161/cc.10.14.15861.
Abstract
摘要
相似文献
1
The dynamic interplay between a PTK (Kit) and a PTP (Shp2) in hematopoietic stem and progenitor cells.
Cell Cycle. 2011 Jul 15;10(14):2241-2. doi: 10.4161/cc.10.14.15861.
2
Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool.
Blood. 2011 May 19;117(20):5350-61. doi: 10.1182/blood-2011-01-333476. Epub 2011 Mar 30.
3
Haematopoietic progenitor cells utilise conventional PKC to suppress PKB/Akt activity in response to c-Kit stimulation.
Br J Haematol. 2007 Jan;136(2):260-8. doi: 10.1111/j.1365-2141.2006.06434.x. Epub 2006 Nov 30.
4
Leukemogenic Ptpn11 allele causes defective erythropoiesis in mice.
PLoS One. 2014 Oct 7;9(10):e109682. doi: 10.1371/journal.pone.0109682. eCollection 2014.
5
A change in structural integrity of c-Kit mutant D816V causes constitutive signaling.
Mutat Res. 2018 Mar;808:28-38. doi: 10.1016/j.mrfmmm.2018.02.001. Epub 2018 Feb 17.
6
Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
Cell Signal. 2006 Sep;18(9):1447-54. doi: 10.1016/j.cellsig.2005.11.005. Epub 2006 Jan 25.
7
Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT.
Blood. 2012 Sep 27;120(13):2669-78. doi: 10.1182/blood-2011-08-375873. Epub 2012 Jul 17.
8
Kit and Scl regulation of hematopoietic stem cells.
Curr Opin Hematol. 2014 Jul;21(4):256-64. doi: 10.1097/MOH.0000000000000052.
9
Increased c-Jun expression and reduced GATA2 expression promote aberrant monocytic differentiation induced by activating PTPN11 mutants.
Mol Cell Biol. 2009 Aug;29(16):4376-93. doi: 10.1128/MCB.01330-08. Epub 2009 Jun 15.
10
Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines.
Blood. 2004 Jul 1;104(1):51-7. doi: 10.1182/blood-2003-07-2554. Epub 2004 Mar 2.
引用本文的文献
1
SHP2 negatively regulates HLA-ABC and PD-L1 expression via STAT1 phosphorylation in prostate cancer cells.
Oncotarget. 2017 Jun 21;8(32):53518-53530. doi: 10.18632/oncotarget.18591. eCollection 2017 Aug 8.
2
Shp2 and Pten have antagonistic roles in myeloproliferation but cooperate to promote erythropoiesis in mammals.
Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):13342-7. doi: 10.1073/pnas.1507599112. Epub 2015 Oct 12.
3
Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition.
Oncogene. 2016 Mar 10;35(10):1271-82. doi: 10.1038/onc.2015.184. Epub 2015 Jun 8.
本文引用的文献
1
Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool.
Blood. 2011 May 19;117(20):5350-61. doi: 10.1182/blood-2011-01-333476. Epub 2011 Mar 30.
2
Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells.
Blood. 2011 Apr 21;117(16):4253-61. doi: 10.1182/blood-2010-11-319517. Epub 2011 Feb 25.
3
The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases.
Blood. 2008 Nov 1;112(9):3543-53. doi: 10.1182/blood-2008-08-078220.
4
Hematopoiesis: an evolving paradigm for stem cell biology.
Cell. 2008 Feb 22;132(4):631-44. doi: 10.1016/j.cell.2008.01.025.
5
PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase.
Blood. 2007 Feb 1;109(3):862-7. doi: 10.1182/blood-2006-07-028829. Epub 2006 Oct 19.
6
Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect.
J Clin Invest. 2006 Oct;116(10):2808-16. doi: 10.1172/JCI28310.
7
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.
J Clin Oncol. 2006 Aug 20;24(24):3904-11. doi: 10.1200/JCO.2006.06.9500.
8
The stem cell niches in bone.
J Clin Invest. 2006 May;116(5):1195-201. doi: 10.1172/JCI28568.
9
Viable c-Kit(W/W) mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis.
Immunity. 2002 Sep;17(3):277-88. doi: 10.1016/s1074-7613(02)00386-2.
10
Early transplantation to a normal microenvironment prevents the development of Steel hematopoietic stem cell defects.
Exp Hematol. 1997 Jun;25(6):542-7.
Zotero 插件